U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07745569) titled 'Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies' on July 29.
Brief Summary: PRE-EMPT will assemble a cohort of 150 participants from three populations (low risk, intermediate risk, and high risk for self-harm). We will obtain clinical assessments, structural and functional MRI utilizing tasks pioneered by our team to assess cognitive control (CC) and emotion regulation (ER), and peripheral circular RNA (circRNA) levels to characterize the molecular brain states associated with behavioral risk. The clinical, imaging, and transcriptomic data will be fused and jointly analyzed to increase the accur...